MATERIALS & CONSUMABLE GOODSNo sanctions match · screened 20 Nov 2026
Johnson & Johnson
jnj.comUpdated 8 Nov 2026
Strategic intent
Johnson & Johnson is a global healthcare leader focused on the research, development, and manufacturing of innovative medicines (pharmaceuticals and biotechnology) and medical technologies (MedTech).
Key market signals
- 2026-11: Johnson & Johnson announced positive Phase 3 results for ICOTYDE (icotrokinra) in biologic-naïve adults with active psoriatic arthritis, demonstrating significant joint and skin improvements.
- 2026-11: The U.S. FDA granted accelerated approval for RYBREVANT FASPRO as a single agent for recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
- 2026-11: J&J presented positive patient experience findings from the Phase 2 DAHLIAS study of nipocalimab in Sjögren's disease at the ACR Convergence 2026.
- 2026-10: J&J reported strong Q3 2026 financial results with 5.9% sales growth to $25.4 Billion and raised its full-year 2026 guidance to $101.2 Billion.
- 2026-10: J&J highlighted significant MedTech innovation with the market authorization of OTTAVA as the world's first table-integrated soft tissue robotic system.
Financial health
- Q3 2026 reported sales grew 5.9% year-over-year to $25.4 Billion, with operational growth of 6.0% (https://www.jnj.com).
- Adjusted EPS for Q3 2026 was $2.59, beating consensus estimates of $2.53 (https://www.jnj.com).
- Raised full-year 2026 guidance to estimated reported sales of $101.2 Billion (7.4% growth at the midpoint) and adjusted EPS of $11.10 (https://www.jnj.com).
Impact & compliance
Social ImpactModern Slavery Statement (2026)Scope 3 data: comprehensiveThird-party assured
Forensic audit
- Oct 2026: In October 2026, Johnson & Johnson agreed to a $4.7 million class action settlement to resolve claims that it violated …
Proprietary analysis
- Log in to see
Strategic fit
AI-calculated strategic alignment score
- Log in to see
Cultural fit
Trust and integrity score
- Log in to see
Alignment dimensions
How this supplier scores against each of your strategic imperatives
- Log in to see
Full forensic analysis
Complete ESG audit, modern slavery risk assessment, labour sentiment analysis, and observed contradictions with evidence trails.
Want the full analysis?
Strategic and cultural fit scoring, full forensic detail and alignment dimensions, for this supplier and your own.